Content Type: Commentary & Opinion

Ensuring Timely Approval of Generic Drugs

March 16, 2026

The Short-Term and Long-Term Outlook of Drug Coupons

March 16, 2026

The Future of Precision Medicine: Great Promise, Significant Challenges

March 16, 2026

To Spur Medical Innovation, Make Corporate Cheaters Pay

March 16, 2026

Expanding Coercive Treatment Is the Wrong Solution for the Opioid Crisis

March 16, 2026

What Do High Drug Prices Buy Us?

March 16, 2026

President Biden Already Has the COVID Vaccine Recipe. He Should Share It

March 16, 2026

Biosimilar Approvals and the BPCIA: Too Soon to Give Up

March 16, 2026

Drugs Don’t Work If People Can’t Afford Them: The High Price of Tisagenlecleucel

March 16, 2026

The Pharmaceutical Market’s Adverse Effects

March 16, 2026

Challenging Patents to Promote Timely Generic Drug Entry: The Second Look Act and Other Options

March 16, 2026

Op-Ed: Do Large Pharma Companies Provide Drug Development Innovation? Our Analysis Says No

March 16, 2026